ImmunoMet Therapeutics

0 followers


ImmunoMet Therapeutics is a clinical stage biotech targeting cellular metabolism to develop novel anti-fibrotic and anti-tumor therapies.

Industries

Headquarters

Stage

Employees

Links

Org chart

Dean Welsch
Chief Executive Officer
Tingchen Cui
Co-chief Executive Officer